Scythian Lamb (Cibotium barometz): A Comprehensive Reference
1. Identity, Nomenclature, and Botanical Description
Common names: Woolly Fern is also known as Jin Mao Gou Ji, Golden Chicken Fern, Scythian Lamb, Golden Moss, Vegetable Lamb, Agneau de Scythie, Tatarenlamm, Skythenlamm, Penawar Jambi, Kinmougoushi, Gugoel, Rhizoma Cibotii, Baranets, Helecho lanudo, Gou Ji, Kut Phan, Wan kai noi, Lông cu li, and Cẩu tÃch.
Accepted botanical name: Cibotium barometz (L.) J. Sm. is a significant tall tree-like fern medicinal plant from the genus Cibotium in the family Dicksoniaceae, which generally grows in the ditch at the foot of the mountain and in acid soil in the shade of trees. One plant bears a host of provocative names: the Vegetable Lamb, Lamb of Tartary, Scythian Lamb (or Agnus scythicus), and, scientifically, Cibotium barometz, the species epithet of which, "barometz," is a Tartarian word for "lamb."
Pharmacopoeial name: Cibotium barometz (L.) J. Sm. is the original species of traditional medicine cibotii rhizoma ("Gouji" in Chinese), the processed rhizome of which can be used in the therapy of pain, weakness, and numbness of the lower extremity (Chinese Pharmacopoeia Commission, 2020).
Morphology: A small tree fern from tropical Asia with delicate but robust, bluish-green fronds and a slender, creeping or short upright trunk that is thickly covered in soft orange hairs, which is why it has been called a "vegetable lamb." The fronds of the remarkable fern typically grow to lengths of 10 ft (3 m) and most commonly develop a light green color. The rhizomes of the species garner the most interest: this part of the plant evolved a covering of long, golden-colored hairs resembling sheep's wool.
Distribution and habitat: Cibotium barometz is found in and around forests, valleys, and other warm and humid places at an altitude of 600 m, but may be found up to 1600 m above sea level. It is found in southern China and central Taiwan, northeast India, Myanmar, Thailand, Vietnam, the Malay Peninsula, Indonesia in Java to Sumatra, and the Ryukyu Islands.
Parts used medicinally: Its rhizomes are often used to treat bone and joint pain, urinary system diseases, male reproductive disorders, female menstrual irregularities, and other diseases. The hairs on its rhizomes are often used to treat ulcers and bleeding.
Common forms and preparations: As a traditional Chinese medicinal material, the primary part used for medicine is the dried rhizome. Based on collection sources, they can be categorized into wild varieties or cultivated ones. In traditional processing techniques, cooked slices are made from raw materials through steaming while controlling appropriate dryness levels — typically around 60–70% dry before slicing — to ensure intact pieces conducive for subsequent uniform drying processes. Processing methods from regions such as Guangxi or Zhejiang feature unique practices where black soybean skins may be added during cooking until discoloration occurs; this method potentially alters active ingredient compositions via biochemical reactions like the Maillard reaction. Modern commercial preparations include both alcohol-based herbal tinctures (using alcohol as the solvent) and alcohol-free glycerites (using vegetable glycerin as the solvent). Concentrated granular extracts are also available: one commercially available format is 100 g (3.5 oz) of concentrated granules extracted from 500 g of the raw herbs.
2. Historical and Traditional Use
2.1 Mythology and the "Vegetable Lamb" Legend
The Vegetable Lamb of Tartary (Latin: Agnus scythicus or Planta Tartarica Barometz) is a legendary zoophyte of Central Asia, once believed to grow sheep as its fruit. It was believed the sheep were connected to the plant by an umbilical cord and grazed the land around the plant. When all accessible foliage was gone, both the plant and sheep died. The 14th-century book The Travels of Sir John Mandeville is credited with bringing the legend to public attention in Europe. It describes a strange gourd-like fruit grown in Tartary. Once ripe, the fruit was cut open, revealing what looked like a lamb in flesh and blood but lacking wool. The fruit and the lamb could then be eaten.
Denis Diderot wrote an article about the vegetable lamb, agnus scythicus, in the first edition (1751) of the Encyclopédie. After describing the purely vegetable nature of the so-called lamb, he noted its potential use as a cure for spitting blood. The legend was eventually demystified as travelers encountered the actual plant and its distinctive woolly rhizomes.
2.2 Traditional Chinese Medicine (TCM)
The dry or processed rhizome of C. barometz has served as traditional Chinese folk medicine Gou-ji (Rhizoma Cibotii) for a long history since the Eastern Han Dynasty (25–220 CE). Gou-ji is listed in the Chinese Pharmacopoeia (2020 Edition) and other folk medicinal formulas. Its clinical applications include kidney tonification, strengthening the lower back, hepatoprotection, and enhancing bone health.
In the 20th and 21st centuries, C. barometz gained formal recognition in Traditional Chinese Medicine (TCM) pharmacopeias, where its rhizome, known as "Gouji" or Rhizoma Cibotii, is listed for tonifying kidney and liver functions, treating rheumatism, and strengthening tendons and bones, as standardized in the Chinese Pharmacopoeia (2020 edition).
In traditional Chinese medicine, Cibotium barometz has a bitter-sweet taste and warm property, and helps nourish the liver and kidneys, strengthen tendons and bones, and reduce rheumatism. Medicinal recipes from it are effective for anti-inflammatory purposes and hemostasis, due in part to the natural properties of the yellowish fur. It is also used to treat rheumatism, colds, back pains, spermatorrhea, vaginal discharge, and urinary incontinence.
2.3 Traditional Use Across Southeast Asia
Cibotium barometz is well valued as a medicinal herb. In traditional medicine, it is believed that the rhizome replenishes the liver and the kidney, strengthens the tendons and bones, and relieves rheumatism conditions. It is widely used to cure rheumatism, limb-ache, lumbago, neuralgia, and pollakiuria in aged humans, and leucorrhoea. It also cures sciatica, micturition, enuresis, and body-ache in pregnant women. The golden hair covering the rhizome is used for poulticing wounds and cuts in the limbs to stop bleeding. According to literature, C. barometz's rhizome is also employed as a tonic and vermifuge.
Cibotium barometz has been traditionally used as an anti-inflammatory and anodyne. Its rhizomes and roots were reported to be collected for medicinal uses, including use as a blood coagulant and treatment of ulcers and rheumatism.
In Malaysia, Cibotium barometz is a pharmaceutical plant customarily used in traditional medicine in Malaysia for the treatment of different diseases, such as gastric ulcer. It is also reportedly used as food, fiber, and packing material, as well as a pot plant.
C. barometz is an ancient fern with a long history as a natural medicine in China, India, Vietnam, and other countries. The dry sliced rhizomes of Cibotium called "Gouji" mainly enter domestic markets for trade, and the largest consumers are factories producing pills of "Zhuangyao Bushen Wan," a medicine considered helpful for maintaining kidney function.
3. Phytochemistry: Key Constituents and Active Compounds
More than 100 compounds have been obtained from C. barometz, including phenylpropanoids, polyphenols, flavonoids, terpenoids, steroids, polysaccharides, and other kinds. Phytochemical research has shown that the extract of its rhizomes is rich in active compounds such as pterosins, terpenes, steroids, flavonoids, glucosides, phenolic acids, and pyrones.
3.1 Pterosins and Ptaquiloside
Pterosin R, pterosin Z, and ptaquiloside were found in C. barometz. Pterosins are a distinctive class of sesquiterpene lactones found across several fern genera, and they have been associated with various bioactivities. Pterosin B and its analogues exhibit anti-osteoarthritis, anti-Alzheimer's disease, neuroprotective, anti-cardiomyocyte hypertrophy, anti-diabetic, and smooth muscle relaxant properties.
3.2 Phenolic Acids and Flavonoids
Phenolic acids and flavonoids, which are prominent plant secondary metabolites, possess significant biological activities, including antioxidant, anti-inflammatory, and antibacterial effects. The pharmacological effects of Gou-ji in traditional Chinese medicine may be attributed primarily to these bioactive constituents. Quantitative analysis of the rhizome has identified specific flavonoids including (-)-epicatechin, apigenin-7-glucoside, naringenin-7-glucoside, vitexin, apigenin, (-)-catechin, eriodictyol, and naringenin chalcone.
3.3 Polysaccharides
Cibotium barometz polysaccharides (CBPS) are one of the most important bioactive components extracted from the Cibotium barometz plant, which belongs to the Dicksoniaceae family. It has been widely used for the treatment of orthopedic diseases. Based on previous studies, CB is composed of polysaccharides, amino acids, flavones, and phenolic acids.
3.4 Rhizome Hair Constituents
Qualitative analysis of the rhizome hairs indicates that the extracts contained anthraquinones, flavonoids, phenolics, tannins, phytosterols, and triterpenoids. The total phenolic and flavonoid contents of the extracts were 0.37–266 mg gallic acid equivalents/g sample and 4.57–113 mg quercetin equivalents/g sample, respectively. GC–MS analysis revealed the presence of 1-nonadecene, Z-5-nonadecene, octacosanol, and 1-tetracosanol/1-heneicosanol in the ethyl acetate extract, which contributed partially to the antioxidant, antibacterial, and antifungal activities. The results indicate that the rhizome hairs are a good source of bioactive compounds with antioxidant and antimicrobial activities.
3.5 Other Compound Classes
Processed products of C. barometz (drying, cutting, roasting, boiling, etc.) contain phenolic compounds, volatile oil, sterols, saccharides, glucosides, amino acids, mineral elements, and phospholipids.
4. Pharmacology and Mechanisms of Action
The long history of the use of C. barometz and its significant clinical effects has attracted great interest from researchers. Some researchers have carried out modern pharmacological studies based on its traditional uses, which not only verified the rationality of its use in traditional medicine but also elaborated on its mechanisms at the cellular and molecular levels and even found some new activities. In recent years, it has been proven that C. barometz has many pharmacological activities in in vivo and in vitro experiments, including anti-osteoporosis activity, anti-microorganism activity, anti-osteoarthritis activity, anti-cancer activity, protective activity on muscle, and alleviating Alzheimer's disease.
4.1 Musculoskeletal System: Osteoporosis
Mechanism (in vitro/animal): Research has confirmed that Cibotium barometz can inhibit osteoclast formation with no effect on bone marrow macrophage (BMM) cell viability.
Animal study — anti-osteoporosis: Research confirmed that Cibotium barometz could inhibit osteoclast formation with no effect on BMM cell viability. However, the influence of Cibotium barometz on osteoporosis in animals was previously relatively unknown. The purpose of one study was to systemically investigate the effects of Cibotium barometz extract (CBE) on ovariectomy-induced osteoporosis in rats. A total of 72 three-month-old female Sprague-Dawley rats were used and randomly divided into a sham-operated group and five ovariectomized (OVX) groups: OVX with vehicle; OVX with 17β-estradiol (E2, 25 μg/kg/day); OVX with CBE of graded doses (100, 300, or 500 mg/kg/day). Daily oral administration of E2 or CBE began 4 weeks after the surgery and lasted for 16 weeks. Bone mass, bone turnover, and strength were analyzed by DEXA, biochemical markers, and three-point bending test. The study concluded that Cibotium barometz extract might be a potential alternative medicine for the prevention and treatment of postmenopausal osteoporosis. This study was conducted in rats; no equivalent human clinical trials are available in the published literature.
4.2 Musculoskeletal System: Osteoarthritis and Chondroprotection
Network pharmacology and in vitro/in vivo (OA): Cibotium barometz is a representative tonifying kidney drug and is widely used for osteoarthritis (OA) in traditional Chinese medicine. However, its regulatory mechanisms in treating OA remain to be sufficiently investigated.
In vivo experiments revealed that Cibotium barometz could effectively restrain cartilage from degeneration and inhibit the mRNA expression of MMP-1, MMP-3, MMP-13, and COX2 in cartilage. In vitro experiments indicated that Cibotium barometz water extract (CBWE) could significantly inhibit the expression of MMP-1, MMP-3, MMP-13, and PGE2 in IL-1β-induced SW1353 cells, and markedly prevent the translocation of NFκB p65 from the cytoplasm to the nuclei and decrease its phosphorylation level. After small-interfering RNA (siRNA) was used to suppress the synthesis of NFκB p65 to block NFκB signaling pathway, the ability of CBWE to inhibit MMP-1, MMP-3, MMP-13, and PGE2 was greatly reduced. Cibotium barometz has a chondroprotective effect on OA by inhibiting the response to inflammation and substrate degradation, and the related mechanism is associated with the inhibition of the NFκB pathway.
Flavonoids have been identified as key components of Cibotium barometz for the treatment of OA in network pharmacology predictions.
Polysaccharides and chondrocyte proliferation (in vitro): A cell viability assay demonstrated that chondrocyte proliferation may be enhanced by CBPS in a dose- and time-dependent manner. The mechanism underlying the promotion of chondrocyte cell cycle was suggested to involve the stimulation of G1 to S phase transition. The results suggested that CBPS may stimulate chondrocyte proliferation via promoting G1/S cell cycle transition. Since osteoarthritis is characterized by deficient proliferation in chondrocytes, this study indicates that CBPS may potentially serve as a novel method for the treatment of osteoarthritis. This was an in vitro study and its findings are preliminary; clinical confirmation is lacking.
4.3 Anti-inflammatory Activity
Relevant studies have shown that active ingredients of Cibotium barometz have various pharmacological properties, such as antioxidant, anti-inflammatory, liver-protecting, and osteoclast-suppressive effects. The NF-κB inhibition pathway, identified in the OA studies above, is a central mechanism underlying its observed anti-inflammatory effects.
4.4 Antioxidant Activity
Bioactivity experiments supported efficacy, including antioxidant and antimicrobial activities, as well as abirritation. One study on the rhizome hair methanolic extract reported a DPPH free-radical scavenging activity of 87.5% with an IC50 value of 30.1 ± 0.05 μg/mL, although a separate study found that a particular extract preparation showed limited antioxidant activity and no antimicrobial or wound-healing efficacy. Results therefore appear to vary by plant part and extraction method used.
4.5 Gastroprotective / Antiulcer Activity
Two closely related rodent studies (one using leaves, one using rhizome hair extract) investigated gastroprotective effects. The aim was to assess the anti-ulcer effects of C. barometz hair on ethanol-induced stomach hemorrhagic abrasions in animals. Seven groups of Sprague-Dawley (SD) rats were administered 10% Tween 20 in the normal control and ulcer control groups, and omeprazole 20 mg/kg and 62.5, 125, 250, and 500 mg/kg of C. barometz hair extract in the experimental groups. Groups given 62.5, 125, 250, and 500 mg/kg doses of C. barometz hair extract had moderate to mild disruptions of the surface epithelium in the gastric mucosa in a dose-dependent manner. Animal groups pre-treated with 500 mg/kg and 250 mg/kg of C. barometz hair exhibited significant increases in mucus weight with respect to the ulcer control group.
Important caveat: The antiulcer leaf study (Al-Wajeeh et al., 2017) was subject to retraction in Drug Design, Development and Therapy on November 29, 2023. The rhizome hair gastric study published in BMC Veterinary Research has also been labeled as retracted. Consequently, these findings should not be taken as reliable evidence of gastroprotective efficacy.
5. Areas of Scientific Study and Evidence Quality by Health Domain
5.1 Bone and Joint Health (Osteoporosis / Osteoarthritis)
This is the most extensively investigated area for C. barometz. In order to find out the material basis of the activity of C. barometz, such as anti-osteoporosis activity and anti-microorganism activity, researchers have performed phytochemical studies on it. Evidence consists of in vitro cell-based studies, animal (rodent) pharmacological studies, and network pharmacology analyses. No randomized controlled clinical trials (RCTs) in human subjects have been identified in the peer-reviewed literature at this time. The evidence remains preclinical and should be characterized as preliminary.
5.2 Anti-inflammatory Effects
In vitro and animal models demonstrate inhibition of NFκB signaling, suppression of MMP enzyme expression, and reduction of inflammatory cytokines (COX2, IL-6, TNF-α, PGE2). The NFκB pathway is involved in the development and progression of OA mainly through its effect on the transcription of inflammatory factors and cartilage matrix hydrolases. After activation of the NFκB pathway, inflammatory mediators such as COX2, IL-6, and TNF-α are transcribed, further exacerbating the inflammatory response in the joint. It is therefore reasonable to assume that Cibotium barometz inhibits COX2, MMP-1, MMP-3, and MMP-13 via the NFκB pathway. This mechanism has not been confirmed in human clinical trials.
5.3 Kidney and Liver Tonification (Traditional Framework)
Clinical applications recorded in TCM include kidney tonification, strengthening the lower back, hepatoprotection, and enhancing bone health. These indications are rooted in TCM theory ("tonifying kidney and liver") rather than in modern biomedical clinical trial evidence. Active ingredients of Cibotium barometz have been documented to show liver-protecting effects in experimental models, but human studies are absent from the published literature.
5.4 Hemostasis (Topical Use of Rhizome Hairs)
The golden hair covering the rhizome is used for poulticing wounds and cuts in the limbs to stop bleeding. According to literature, C. barometz's rhizome is also employed as a tonic and vermifuge. The hair, in suitable application, can arrest capillary bleeding by mechanical action. This topical hemostatic use is documented ethnobotanically and is mechanistically plausible given the fibrous physical properties of the golden hairs, but has not been the subject of rigorous clinical trials.
5.5 Antimicrobial Activity
Results across studies are mixed. One analysis of rhizome hair extracts found evidence of antioxidant and antimicrobial activity, while another found that a methanolic extract of golden hairs showed no inhibition zones against Staphylococcus aureus, Bacillus cereus, Escherichia coli, and Serratia marcescens using agar well diffusion, indicating a lack of antimicrobial activity. This inconsistency may reflect differences in extraction solvent, part of the plant used, and the specific microbial strains tested. The evidence is insufficient to draw conclusions about clinical antimicrobial utility.
5.6 Additional Areas Under Investigation
Pharmacological activities documented in experimental models also include anti-cancer activity, protective activity on muscle, and alleviation of Alzheimer's disease symptoms. These are preliminary findings from in vitro or animal work and have not been substantiated in human studies.
6. Dosage Forms and Reported Dosages
No formally established therapeutic dosages for human use have been set by regulatory bodies. The following dosages appear only in the experimental (preclinical) studies reviewed:
- Ovariectomized rat osteoporosis model (oral): Daily oral administration of CBE was tested at graded doses of 100, 300, or 500 mg/kg/day for 16 weeks.
- Rat gastric hair extract model (oral): 62.5, 125, 250, and 500 mg/kg of C. barometz hair extract in experimental groups, compared to omeprazole at 20 mg/kg. (Note: the related leaf study has been retracted; the hair study is also labeled retracted.)
- Acute toxicity rat model: Rats treated with 2 g/kg and 5 g/kg of the Cibotium barometz extract showed no significant changes in the structures of livers and kidneys between the treated and control groups.
In domestic traditional medicine markets, the dry sliced rhizomes enter commerce primarily for use in factories producing pills of "Zhuangyao Bushen Wan," a traditional kidney-support formulation. Standardized dosage information for this or other finished TCM products is regulated under the Chinese Pharmacopoeia and is not directly extrapolated to individual supplement use.
7. Conservation Status and Regulatory Considerations
Cibotium barometz is regulated under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) Appendix II, a listing in place since 1976 that mandates export permits and non-detriment findings (NDFs) to ensure trade does not threaten wild populations. China's 2008 NDF established an annual export quota of 130 tons, with harvesting restricted to areas outside protected zones and requiring permits from provincial forestry authorities.
Nationally, the species holds protected status in China as a Class II nationally protected wild plant, where harvesting is banned without permits and wild collection is limited to non-reserve areas to curb overexploitation. Long-history medicinal use has caused serious wild population decline in China.
China banned the export of the Scythian Lamb in 1977. At that time, government officials took the action due to a marked decrease in its numbers. Sadly, the species continues to be heavily harvested in portions of Southeast Asia for local medicinal uses.
Under modern cultivation techniques, Cibotium barometz generally requires over five years of growth before meeting medicinal standards.
8. Safety Considerations and Notable Interactions
8.1 Ptaquiloside: A Notable Safety Concern
Ptaquiloside molecules have been found not only in Pteridium species but also in Cibotium barometz (family Cybotiaceae). Ptaquiloside is the primary toxic compound in bracken fern (Pteridium aquilinum). It is a problematic, dangerous, and poisonous compound due to its special chemical composition. It has been found in all parts of the plant including fronds, leaves, rhizomes, and roots. However, the concentration detected in C. barometz and whether traditional processing methods adequately reduce it have not been comprehensively characterized in the published literature reviewed.
It is additionally noteworthy that pterosins more broadly, including ptaquiloside found in the related genus Pteridium, have a dual character: Ptaquiloside also induces apoptosis in certain human cancer cell lines and acts as an anticancer agent. Therefore, pterosins and ptaquiloside have therapeutic properties. This does not eliminate concerns about carcinogenic potential at higher exposures from chronic use.
8.2 Acute Toxicity Data (Animal)
In acute toxicity experiments in rodents, rats treated with 5 g/kg of the C. barometz extract showed no significant changes in the structures of livers and kidneys between the treated and control groups. These are animal-model findings and cannot be directly extrapolated to human safety.
8.3 Absence of Human Clinical Safety Data
No published human clinical trials investigating the safety, tolerability, or drug interactions of Cibotium barometz as a standalone supplement have been identified in peer-reviewed sources. A major challenge hindering the research and use of C. barometz is the sharp decline in the amount of wild resources, which itself limits availability for research. No established recommended dosages or formally approved health claims have been issued by major international regulatory bodies (e.g., EFSA, FDA, EMA) specifically for Cibotium barometz as a dietary supplement ingredient.
8.4 Retracted Studies
The gastroprotective leaf and rhizome hair studies (Al-Wajeeh et al., 2017, and the associated hair study) were formally retracted. A retraction notice was issued in Drug Design, Development and Therapy on November 29, 2023 (doi: 10.2147/DDDT.S451967). Researchers and practitioners relying on this literature should be aware that these findings cannot be considered credible.
8.5 Mold Susceptibility
The medicinal material is very susceptible to mold and should be stored in a dry place. Improper storage conditions may lead to fungal contamination, which is a quality and safety concern for commercial preparations.
9. Overall Evidence Assessment
The scientific evidence base for Cibotium barometz as a dietary supplement ingredient is preliminary and preclinical. The most well-developed research concerns musculoskeletal conditions (osteoporosis and osteoarthritis), where animal and in vitro studies suggest biologically plausible mechanisms involving NFκB inhibition, osteoclast suppression, and chondrocyte proliferation. The long history of the use of C. barometz and its significant clinical effects has attracted great interest from researchers. Some researchers have carried out modern pharmacological studies based on its traditional uses, which not only verified the rationality of its use in traditional medicine but also elaborated on its mechanisms at the cellular and molecular levels. However, the transition from preclinical to human clinical evidence has not yet occurred for any indication. Until rigorous randomized controlled trials in human populations are conducted, any health claims remain unsupported by clinical evidence.
References
Go back